Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer-Reference-Cited by-同舟云学术

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer

Published:2019-12-19 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Zhou Hai-Hong,Chen Xu,Cai Lu-Ya,Nan Xing-Wei,Chen Jia-Hua,Chen Xiu-Xiu,Yang Yang,Xing Zi-Hao,Wei Meng-Ning,Li Yao,Wang Sheng-Te,Liu Kun,Shi Zhi,Yan Xiao-Jian

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference45 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin.,2019

2. Cancer of the ovary;Matulonis;N Engl J Med.,2005

3. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ledermann;Ann Oncol.,2018

4. Epidemiology of ovarian cancer: a review;Reid;Cancer Biol Med.,2017

5. Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer;Zahedi;Mol Pharm.,2011

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential;Non-coding RNA Research;2024-12

2. Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells;European Journal of Medicinal Chemistry;2024-10

3. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-08-16

4. Ferroptosis: mechanism, immunotherapy and role in ovarian cancer;Frontiers in Immunology;2024-08-13

5. Mechanisms of Cell Death Induced by Erastin in Human Ovarian Tumor Cells;International Journal of Molecular Sciences;2024-08-08